Prescription drug costs

FILE - In this Nov. 5, 2018 file photo, a drugstore employee reaches for medicine from shelf in downtown Tehran, Iran. According to a study published in the British journal Lancet on Thursday, Aug. 22, 2019, researchers say a cheap daily pill that combines four drugs cut the risk of heart attacks, strokes and heart failure in a large study, suggesting it could be a good way to prevent heart problems. (AP Photo/Ebrahim Noroozi)
August 22, 2019 - 9:12 pm
LONDON (AP) — A cheap daily pill that combines four drugs cut the risk of heart attacks, strokes and heart failure in a large study, suggesting it could be a good way to help prevent heart problems especially in poor countries. The pills contained two blood pressure drugs, a cholesterol medicine...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 1:41 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 8:48 am
WASHINGTON (AP) — The Latest on President Donald Trump's plan to lower prescription drug prices (all times local): 11:40 a.m. The drug industry lobby says the Trump administration's plan to let Americans import cheaper prescription drugs from Canada is "far too dangerous." Pharmaceutical Research...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 1:05 am
WASHINGTON (AP) — The Trump administration is working on a plan that would allow Americans to import lower-priced prescription drugs from Canada, Health and Human Services Secretary Alex Azar said Tuesday. Azar made his comments during an interview with CNBC, saying he had just gotten off the phone...
Read More
FILE - In this June 18, 2019, file photo, U.S. Trade Representative Robert Lighthizer testifies before the Senate Finance Committee on Capitol Hill in Washington. Congressional Democrats appear to be moving from “no way’’ to “maybe’’ on President Donald Trump’s rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with Lighthizer, most recently on Friday, July 26, and both sides say they are making progress toward a deal that would clear the way for Congress to approve Trump’s U.S.-Mexico-Canada Agreement, or USMCA. (AP Photo/Susan Walsh, File)
July 29, 2019 - 9:30 pm
WASHINGTON (AP) — Congressional Democrats appear to be moving from "no way" to "maybe" on President Donald Trump's rewrite of a trade pact with Canada and Mexico. House Democrats have met four times with U.S. Trade Representative Robert Lighthizer, most recently on Friday, and both sides say they...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 12:59 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 7:49 am
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. The two companies said Monday that they'll ultimately spin off the combination of Mylan, a $10 billion company, with Pfizer...
Read More
July 25, 2019 - 12:10 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
House Speaker Nancy Pelosi of Calif. and House Democrats arrive for a news conference on the first 200 days of the 116th Congress at the House east front steps on Capitol Hill, in Washington, Thursday, July 25, 2019. (AP Photo/Andrew Harnik)
July 25, 2019 - 9:30 am
WASHINGTON (AP) — Congressional Democrats on Thursday pivoted away from questions of impeachment by saying they are going to "own" the upcoming August recess on issues like health care and prescription drug costs. Not emphasized was the testimony a day earlier by former special counsel Robert...
Read More
July 23, 2019 - 7:27 am
WASHINGTON (AP) — Two senior senators — one Republican, one Democrat — are unveiling compromise legislation to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs. Staffers for Iowa Republican Charles Grassley and Oregon...
Read More

Pages